Data Sources: PubMed was searched (to December 5, 2011) using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted ...
It was noninferior to basal glargine, and one head-to-head trial showed once-weekly exenatide to be inferior to liraglutide. Albuglutide was noninferior to prandial lispro with significantly less ...
GLP-1s currently used for weight loss—although not all are expressly approved for this purpose—include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and ...
The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.
Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs used to treat people with type 2 diabetes. The drugs, classified as GLP-1 agonists, have also been used for weight loss in ...
Egypt: A recent study published in the Indian Journal of Critical Care Medicine has compared the efficacy of ultra-long-acting insulin degludec with the commonly used insulin glargine in managing ...
Discover the FDA-approved indications for GLP-1 receptors, including diabetes, weight loss, and cardiovascular disease. Learn brand-name and generic options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback